[Comparative cost of treatment of chronic complicated chlamydiosis of the urogenital system with some fluoroquinolones and macrolides].
The article is devoted to the problem of the health care delivery to patients with chlamydiosis of the urogenital system. A comparative study was made of the cost of the course of treatment of chlamydiosis with different antibiotics. These included fluorochinolons cyprobai (Bayer), cyprinol (KRKA), ophloxin (Lechiva) and macrolids clacid (Sanofi-Synthelabo), phromilid (KRKA) and rovamycin (Rhone-Poulenc-Rorer). Economic expediency is proved of employment of cyprinol (KRKA) and phrolimid (KRKA), which fact is related to a high drugs clinical efficiency, quality of these drugs and optimum pricing policy carried on by the KRKA company on the market of Ukraine.